P.M.L.H. Vencken

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients

P.M.L.H. Vencken, Mieke Kriege, D. Hoogwerf et al. · Annals of Oncology · 2011 · 212 citations · Full text

Medicine, Cancer Management, Gynecology +8

The risk of primary and contralateral breast cancer after ovarian cancer in <i>BRCA1</i>/<i>BRCA2</i> mutation carriers

P.M.L.H. Vencken, Mieke Kriege, Maartje J. Hooning et al. · Cancer · 2012 · 38 citations · Full text

Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the ‘Dutch Gynecological Oncology Audit’

Marc Daniël Algera, Willemien J. van Driel, B.F.M. Slangen et al. · Gynecologic Oncology · 2022 · 31 citations · Full text

Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands

P.M.L.H. Vencken, Welmoed Reitsma, Mieke Kriege et al. · Annals of Oncology · 2013 · 22 citations · Full text

Cancer Risk, Cancer Epidemiology, Brca2-associated Ovarian Cancer +10

Conservative management in breech deliveries leads to similar results compared with cephalic deliveries

J. F. M. Molkenboer, P.M.L.H. Vencken, L. G. J. Sonnemans et al. · The Journal of Maternal-Fetal & Neonatal Medicine · 2007 · 20 citations